Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.
Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group. Toes-Zoutendijk E, et al. Among authors: de koning hj. Clin Gastroenterol Hepatol. 2020 Jun;18(7):1493-1500. doi: 10.1016/j.cgh.2019.08.021. Epub 2019 Aug 20. Clin Gastroenterol Hepatol. 2020. PMID: 31442598 Free article.
Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X, van Leeuwen PJ, Bul M, Otto SJ, de Koning HJ, Bangma CH, Schröder FH, Roobol MJ. Zhu X, et al. Among authors: de koning hj. Eur Urol. 2011 Aug;60(2):330-6. doi: 10.1016/j.eururo.2011.05.013. Epub 2011 May 17. Eur Urol. 2011. PMID: 21601352 Clinical Trial.
Mammography screening and risk of breast cancer death: a population-based case-control study.
Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerink-Verheij JC, Otten JD, Broeders MJ, de Koning HJ; National Evaluation Team for Breast Cancer Screening. Otto SJ, et al. Among authors: de koning hj. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):66-73. doi: 10.1158/1055-9965.EPI-11-0476. Epub 2011 Dec 6. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22147362
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. van Ravesteyn NT, et al. Among authors: de koning hj. Ann Intern Med. 2012 May 1;156(9):609-17. doi: 10.7326/0003-4819-156-9-201205010-00002. Ann Intern Med. 2012. PMID: 22547470 Free PMC article.
Quality-of-life effects of prostate-specific antigen screening.
Heijnsdijk EA, Wever EM, Auvinen A, Hugosson J, Ciatto S, Nelen V, Kwiatkowski M, Villers A, Páez A, Moss SM, Zappa M, Tammela TL, Mäkinen T, Carlsson S, Korfage IJ, Essink-Bot ML, Otto SJ, Draisma G, Bangma CH, Roobol MJ, Schröder FH, de Koning HJ. Heijnsdijk EA, et al. Among authors: de koning hj. N Engl J Med. 2012 Aug 16;367(7):595-605. doi: 10.1056/NEJMoa1201637. N Engl J Med. 2012. PMID: 22894572 Free PMC article.
Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N, van der Aalst CM, Thunnissen E, Nackaerts K, Weenink C, Groen HJ, Lammers JW, Aerts JG, Scholten ET, van Rosmalen J, Mali W, Oudkerk M, de Koning HJ. Horeweg N, et al. Among authors: de koning hj. Am J Respir Crit Care Med. 2013 Apr 15;187(8):848-54. doi: 10.1164/rccm.201209-1651OC. Am J Respir Crit Care Med. 2013. PMID: 23348977 Clinical Trial.
Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: a randomized controlled trial.
van Leeuwen PJ, Kranse R, Hakulinen T, Hugosson J, Tammela TL, Ciattoy S, Roobol MJ, Zappa M, de Koning HJ, Bangma CH, Moss SM, Auvinen A, Schröder FH. van Leeuwen PJ, et al. Among authors: de koning hj. J Med Screen. 2013 Mar;20(1):33-8. doi: 10.1177/0969141313476632. J Med Screen. 2013. PMID: 23390203 Clinical Trial.
[Effects of the population screening into breast cancer].
Verbeek AL, Broeders MJ, Otto SJ, Frachebou J, Otten JD, Holland R, den Heeten GJ, de Koning HJ. Verbeek AL, et al. Among authors: de koning hj. Ned Tijdschr Geneeskd. 2013;157(10):A5218. Ned Tijdschr Geneeskd. 2013. PMID: 23464582 Review. Dutch.
499 results